Monopar Therapeutics (MNPR) Interest & Investment Income (2023 - 2025)
Monopar Therapeutics' (MNPR) quarterly Interest & Investment Income came in at $655473.0 in Q3 2025, up 559.8% year-on-year from $99344.0 in Q3 2024, and down 16.05% quarter-over-quarter from $780769.0 in Q2 2025.
Monopar Therapeutics (MNPR) Interest & Investment Income (2023 - 2025) Analysis & Trends
Monopar Therapeutics has disclosed Interest & Investment Income across 3 years of filings, most recently posting $655473.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Monopar Therapeutics | 441.25 Mn | 441.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 655,473.00 |
| Jun 30, 2025 | 780,769.00 |
| Mar 31, 2025 | 596,845.00 |
| Sep 30, 2024 | 99,344.00 |
| Jun 30, 2024 | 73,475.00 |
| Mar 31, 2024 | 82,165.00 |
| Sep 30, 2023 | 112,260.00 |